Loading clinical trials...
Loading clinical trials...
Based on the use of the patient's natural defences, immunotherapy mobilizes the immune system to recognize and destroy cancer cells, and it has revolutionized the treatment of lung cancer. However, t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire Dijon
NCT07227298 · Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, and more
NCT06417814 · Metastatic Non-small Cell Lung Cancer
NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer
NCT06996782 · Advanced or Metastatic Non-small Cell Lung Cancer
NCT06975293 · Metastatic Non-small Cell Lung Cancer, Metastatic Melanoma, and more
Chu Dijon Bourgogne
Dijon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions